Clinical Events Avoided with Apixaban Compared to Edoxaban for the Initial Treatment and Prevention of Venous Thromboembolism
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.117
https://www.valueinhealthjournal.com/article/S1098-3015(16)00185-6/fulltext
Section Title :
Cardiovascular Disorders - Cost Studies
Section Order :
1451
First Page :
A48
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00185-6&doi=10.1016/j.jval.2016.03.117